Literature DB >> 7236542

Lymphocyte reactivity of workers exposed to carcinogenic and non-carcinogenic chemicals.

S Kumar, G Taylor, W Hurst, P Wilson, C B Costello.   

Abstract

Immunological studies have shown an increased lymphocyte reactivity in patients with early stage bladder cancer and individuals with pre-stage T1 exposed to bladder carcinogens (2-naphthylamine and industrial 1-naphthylamine containing 4-8% 2-naphthylamine) before 1952-that is, those at high risk of developing bladder cancer. Because of the close chemical similarity of Tobias acid (2-naphthylamine-1 sulphonic acid) to 2-naphthylamine, the lymphocytotoxicity of workers exposed to this chemical was investigated. The results show that the workers using Tobias acid unlike those exposed to 2-naphthylamine have lymphocytes with a normal range of reactivity towards bladder cancer cells, which is in keeping with the suggestion that Tobias acid is non-carcinogenic. The probable reason for its non-carcinogenicity is that the relatively very large size and hydropholic properties of the sulphonic acid group prevents enzymic action on the amino group by steric hindrance. The present lymphocytotoxicity results strengthens our earlier conclusion that the observed increased lymphocyte reactivity in workers exposed to bladder carcinogens is specific.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236542      PMCID: PMC1008840          DOI: 10.1136/oem.38.2.167

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  8 in total

1.  The first reported cases of human bladder tumors due to a new carcinogen-xenylamine.

Authors:  W F MELICK; H M ESCUE; J J NARYKA; R A MEZERA; E P WHEELER
Journal:  J Urol       Date:  1955-12       Impact factor: 7.450

2.  Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine.

Authors:  R A CASE; M E HOSKER; D B McDONALD; J T PEARSON
Journal:  Br J Ind Med       Date:  1954-04

3.  Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

Authors:  C O'Toole; P Perlmann; B Unsgaard; G Moberger; F Edsmyr
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

4.  Benzidine exposure as a cause of bladder tumors.

Authors:  M R Zavon; U Hoegg; E Bingham
Journal:  Arch Environ Health       Date:  1973-07

5.  Immune response to urinary bladder tumours in man.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-01-15       Impact factor: 7.396

6.  Cellular and humoral immune responses to human urinary bladder carcinomas.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

7.  Prognostic importance of specific immunoreactivity in occupational bladder cancer.

Authors:  S Kumar; G Taylor; P Wilson; W Hurst
Journal:  Br Med J       Date:  1980-02-23

8.  Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.

Authors:  M Troye; M Vilien; G R Pape; P Perlmann
Journal:  Int J Cancer       Date:  1980-01-15       Impact factor: 7.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.